FDA Grants Accelerated Approval for Drug that Slows Alzheimer's Disease
Sara Murphy, Vice President of Programs and Services for the Greater Pennsylvania Chapter, spoke with Erie News Now about the FDA approval of lecanemab.
Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.